# enGene Therapeutics Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/engene-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:48:24.063818+00:00 | | Last reviewed | 2026-10-17T04:48:24.063818+00:00 | ## Identity - Legal name: enGene Therapeutics Inc. - Display name: enGene Therapeutics Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T05:25:38.534456+00:00 | | Completeness | 0.318 | | Record Quality | 0.797 | | Directors | 6 | | Committees | 6 | | Governance events | 0 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | NOT_REVIEWED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | INSUFFICIENT_EVIDENCE | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Gerald Brunk: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:leadership_role:7 - Jasper Bos: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:leadership_role:8 - Lota S. Zoth: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Audit (chair); Audit · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:leadership_role:9 - Paul Hastings: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Compensation (member); Compensation; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:leadership_role:10 - Ronald H.W. Cooper: Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:leadership_role:11 - Wouter Joustra: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. Committees: Compensation (member). claim_id=alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:leadership_role:12 ## Committees - Audit (audit). Chair: Lota S. Zoth. Members: Lota S. Zoth (chair, current); Gerald Brunk (member, current). committee_id=alpha:committee:engene-therapeutics-inc:audit - Audit · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Lota S. Zoth (member, unknown). committee_id=alpha:committee:engene-therapeutics-inc:audit-chair-nominating-and-governance - Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Gerald Brunk (member, unknown). committee_id=alpha:committee:engene-therapeutics-inc:audit-compensation-chair - Compensation (compensation). Chair: Gerald Brunk. Members: Gerald Brunk (chair, current); Paul Hastings (member, current); Wouter Joustra (member, current). committee_id=alpha:committee:engene-therapeutics-inc:compensation - Compensation; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Paul Hastings (member, unknown). committee_id=alpha:committee:engene-therapeutics-inc:compensation-nominating-and-governance - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Jasper Bos (member, current); Lota S. Zoth (member, current); Paul Hastings (member, current). committee_id=alpha:committee:engene-therapeutics-inc:nominating-and-governance ## Scoped resources - `alpha://company/engene-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record - `alpha://company/engene-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=identity - `alpha://company/engene-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/engene-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=board - `alpha://company/engene-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=committees - `alpha://company/engene-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=leadership - `alpha://company/engene-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=ownership - `alpha://company/engene-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=financials - `alpha://company/engene-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/engene-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=compensation - `alpha://company/engene-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=governance - `alpha://company/engene-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/engene-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=audit - `alpha://company/engene-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=legal - `alpha://company/engene-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=risk - `alpha://company/engene-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=cyber - `alpha://company/engene-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/engene-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=agents - `alpha://company/engene-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/engene-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=events - `alpha://company/engene-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=relationships - `alpha://company/engene-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=assessments - `alpha://company/engene-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:lota-s-zoth","name":"Lota S. Zoth"},"source_id":"board_seats"}` - Claim alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:gerald-brunk","name":"Gerald Brunk"},"source_id":"board_seats"}` - Claim alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:gerald-brunk","name":"Gerald Brunk"},"source_id":"board_seats"}` - Claim alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:paul-hastings","name":"Paul Hastings"},"source_id":"board_seats"}` - Claim alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:wouter-joustra","name":"Wouter Joustra"},"source_id":"board_seats"}` - Claim alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jasper-bos","name":"Jasper Bos"},"source_id":"board_seats"}` - Claim alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:lota-s-zoth","name":"Lota S. Zoth"},"source_id":"board_seats"}` - Claim alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:paul-hastings","name":"Paul Hastings"},"source_id":"board_seats"}` ## Leadership - Gerald Brunk: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a330dba604ecc81e63f7fb106193b6ad3dfaf024132da1d57423456dd1e58ee. - Jasper Bos: Director, Nominating and Governance. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a330dba604ecc81e63f7fb106193b6ad3dfaf024132da1d57423456dd1e58ee. - Lota S. Zoth: Director, Audit · Chair; Nominating and Governance. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a330dba604ecc81e63f7fb106193b6ad3dfaf024132da1d57423456dd1e58ee. - Paul Hastings: Director, Compensation; Nominating and Governance. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a330dba604ecc81e63f7fb106193b6ad3dfaf024132da1d57423456dd1e58ee. - Ronald H.W. Cooper: Director. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a330dba604ecc81e63f7fb106193b6ad3dfaf024132da1d57423456dd1e58ee. - Wouter Joustra: Director, Compensation. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a330dba604ecc81e63f7fb106193b6ad3dfaf024132da1d57423456dd1e58ee. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Lota S. Zoth; Members Lota S. Zoth (Chair); Gerald Brunk. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c0c87d66c1f778b8ea2f306b7cb50ebfb48bb97feaafb0a392303908dddaaa4e. - Compensation: Chair Gerald Brunk; Members Gerald Brunk (Chair); Paul Hastings; Wouter Joustra. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c0c87d66c1f778b8ea2f306b7cb50ebfb48bb97feaafb0a392303908dddaaa4e. - Nominating and Governance: Chair not stated; Members Jasper Bos; Lota S. Zoth; Paul Hastings. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c0c87d66c1f778b8ea2f306b7cb50ebfb48bb97feaafb0a392303908dddaaa4e. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - enGene Therapeutics Inc.. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e4e59093df87866423736255b8ee812e470f883c6b21be36a981f9d5495b8ba. ## Entity Status - Public listing published. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e4e59093df87866423736255b8ee812e470f883c6b21be36a981f9d5495b8ba. ## Published Fact - US. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e4e59093df87866423736255b8ee812e470f883c6b21be36a981f9d5495b8ba. - Healthcare. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e4e59093df87866423736255b8ee812e470f883c6b21be36a981f9d5495b8ba. - Biotechnology. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e4e59093df87866423736255b8ee812e470f883c6b21be36a981f9d5495b8ba. ## Committee Appointment - Lota S. Zoth: chair, Audit. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c0c87d66c1f778b8ea2f306b7cb50ebfb48bb97feaafb0a392303908dddaaa4e. - Gerald Brunk: member, Audit. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c0c87d66c1f778b8ea2f306b7cb50ebfb48bb97feaafb0a392303908dddaaa4e. - Gerald Brunk: chair, Compensation. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c0c87d66c1f778b8ea2f306b7cb50ebfb48bb97feaafb0a392303908dddaaa4e. - Paul Hastings: member, Compensation. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c0c87d66c1f778b8ea2f306b7cb50ebfb48bb97feaafb0a392303908dddaaa4e. - Wouter Joustra: member, Compensation. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c0c87d66c1f778b8ea2f306b7cb50ebfb48bb97feaafb0a392303908dddaaa4e. - Jasper Bos: member, Nominating and Governance. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c0c87d66c1f778b8ea2f306b7cb50ebfb48bb97feaafb0a392303908dddaaa4e. - Lota S. Zoth: member, Nominating and Governance. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c0c87d66c1f778b8ea2f306b7cb50ebfb48bb97feaafb0a392303908dddaaa4e. - Paul Hastings: member, Nominating and Governance. Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c0c87d66c1f778b8ea2f306b7cb50ebfb48bb97feaafb0a392303908dddaaa4e. ## Security Listing - ENGN (NASDAQ). Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e4e59093df87866423736255b8ee812e470f883c6b21be36a981f9d5495b8ba. - ENGNW (NASDAQ). Claim: alpha:claim:company:9b01a98d-7633-4d3c-a6d6-4d6f12faa348:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e4e59093df87866423736255b8ee812e470f883c6b21be36a981f9d5495b8ba. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:6e4e59093df87866423736255b8ee812e470f883c6b21be36a981f9d5495b8ba: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/engene-therapeutics-inc). - alpha:projection-evidence:document:7a330dba604ecc81e63f7fb106193b6ad3dfaf024132da1d57423456dd1e58ee: [enGene Holdings Inc. DEF 14A 2025-05-09](https://www.sec.gov/Archives/edgar/data/1980845/000114036125018155/ef20048337_def14a.htm). - alpha:projection-evidence:c0c87d66c1f778b8ea2f306b7cb50ebfb48bb97feaafb0a392303908dddaaa4e: [Audit](https://www.sec.gov/Archives/edgar/data/1980845/000114036125018155/ef20048337_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/engene-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/engene-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/engene-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/engene-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T05:25:38.336618+00:00; recorded 2026-10-17T05:25:38.336618+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.